Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bifidobacterium lactis for relieving asthma and application of bifidobacterium lactis

A technology for Bifidobacterium lactis and asthma, applied in the field of microorganisms, can solve problems such as difficulty in curing asthma, and achieve the effects of reducing abundance, increasing abundance and reducing metabolic pathways

Active Publication Date: 2020-08-21
BEIJING SCITOP BIO TECH CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Asthma is not easy to be cured, and drugs are generally used for treatment. Traditionally, hormone drugs are commonly used to treat asthma, which can relieve the patient's condition, but it will bring certain side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bifidobacterium lactis for relieving asthma and application of bifidobacterium lactis
  • Bifidobacterium lactis for relieving asthma and application of bifidobacterium lactis
  • Bifidobacterium lactis for relieving asthma and application of bifidobacterium lactis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0046] Example: Bifidobacterium lactis Probio-M8 Clinical Trial on Asthma Population

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a bifidobacterium lactis Probio-M8 for relieving asthma and an application of the bifidobacterium lactis Probio-M8. The bifidobacterium lactis Probio-M8 has the effect of relieving asthma. The application of the bifidobacterium lactis Probio-M8 comprises the step of preparing a functional health care product by using the bifidobacterium lactis Probio-M8. The application of the bifidobacterium lactis Probio-M8 in relieving asthma comprises: preparing a ready-to-use starter, a probiotic solid beverage, tabletted sweets and functional medicine auxiliary materials. The invention further discloses an application of the traditional Chinese medicine composition, wherein the viable count of the bifidobacterium lactis ProbiO-M8 is greater than or equal to 1*10<6> CFU / g in theapplication of relieving asthma. The product for relieving asthma comprises food and health food. The product for relieving asthma comprises a bean product, a dairy product or a fruit and vegetable product produced by using a leavening agent containing the bifidobacterium lactis ProbiO-M8.

Description

technical field [0001] The application relates to the technical field of microbes, in particular to a strain of bifidobacterium lactis for alleviating asthma and its application. Background technique [0002] Asthma is a common respiratory disease characterized by recurrent attacks. The onset is more acute, manifested as cough, chest tightness and dyspnea. If it is not treated in time, it will endanger life. The prevalence of asthma among adults in my country is 1.24%. The disease is more likely to occur in people with family history of asthma, comorbidities, obesity, smoking and allergen exposure. Due to urbanization and lifestyle changes, the prevalence of asthma is increasing year by year. According to the analysis of the WHO online death database, the asthma death data of the 5-34 age group shows that the global mortality rate of asthma is 0.19 / 100,000 people. [0003] Asthma is not easy to be cured, and drugs are generally used for treatment. Traditionally, hormone dr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/20A23L33/135A23L2/39A23G3/36A23C11/10A23C9/12A23L19/00C12R1/01A23L11/50A23L11/65
CPCC12N1/20A23L33/135A23L2/39A23G3/366A23C11/106A23C9/1203A23L19/00A23V2002/00C12R2001/01C12N1/205A23V2400/531A23V2200/314
Inventor 刘晓军马杰张凌宇张建军其木格苏都杨慧娟
Owner BEIJING SCITOP BIO TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com